norfloxacin has been researched along with Infection, Wound in 7 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, D | 1 |
| Yang, Y | 1 |
| Lu, J | 1 |
| Yuan, Z | 1 |
| Zhang, Y | 1 |
| Yang, X | 1 |
| Huang, X | 1 |
| Li, T | 1 |
| Tian, X | 1 |
| Xu, B | 1 |
| Wang, P | 1 |
| Lei, H | 1 |
| García-Villén, F | 1 |
| Faccendini, A | 1 |
| Aguzzi, C | 1 |
| Cerezo, P | 1 |
| Bonferoni, MC | 1 |
| Rossi, S | 1 |
| Grisoli, P | 1 |
| Ruggeri, M | 1 |
| Ferrari, F | 1 |
| Sandri, G | 1 |
| Viseras, C | 1 |
| Modak, SM | 1 |
| Fox, CL | 1 |
| Huo, ZL | 1 |
| Wang, DW | 1 |
| Mirza, RA | 1 |
| Bux, Q | 1 |
| Ge, SD | 1 |
1 review available for norfloxacin and Infection, Wound
| Article | Year |
|---|---|
[Prospects of clinical uses of quinolones in burn wound infections].
Topics: Animals; Anti-Infective Agents; Burns; Ciprofloxacin; Humans; Norfloxacin; Wound Infection | 1990 |
6 other studies available for norfloxacin and Infection, Wound
| Article | Year |
|---|---|
Injectable Carrier-Free Hydrogel Dressing with Anti-Multidrug-Resistant
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arginine; Bandages; Humans; Hydrogels; Interleukin- | 2022 |
Montmorillonite-norfloxacin nanocomposite intended for healing of infected wounds.
Topics: Adsorption; Anti-Infective Agents; Bentonite; Biological Availability; Drug Liberation; Humans; Male | 2019 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mi | 1981 |
[Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats].
Topics: Administration, Topical; Animals; Anti-Infective Agents; Burns; Female; Fluoroquinolones; Male; Norf | 1993 |
Norfloxacin in wound infections.
Topics: Humans; Norfloxacin; Wound Infection; Wounds, Gunshot | 1988 |
[The effect of pyridonic acid derivatives as topical antibiotics on the prevention and treatment of pyocyaneous infection following burn].
Topics: Administration, Topical; Animals; Burns; Male; Mice; Norfloxacin; Pseudomonas Infections; Rabbits; S | 1987 |